Showing results (251-260 of 425) with videos related to
Sort By:
Pageof 43
Oncotarget|September 3, 2016
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrenceElizabeth A Mittendorf, Alexandros Ardavanis, Jennifer K Litton, et al.Journal of the National Cancer Institute|May 19, 2021
Expanding Criteria for Prognostic Stage IA in Hormone Receptor-Positive Breast CancerOlga Kantor, Tari A King, Steven Shak, et al.Journal of Cancer Survivorship : Research and Practice|August 30, 2025
Impact of age and treatment-related adverse events on financial toxicity among patients with breast cancer: a systematic reviewSara P Myers, Claire R Morton, Paul A Bain, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 8, 2018
Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudyJane M Armer, Karla V Ballman, Linda McCall, et al.Cancer|October 13, 2011
Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02Elizabeth A Mittendorf, Guy T Clifton, Jarrod P Holmes, et al.Annals of Surgical Oncology|June 10, 2020
Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast CancerMichael D Alvarado, Elizabeth A Mittendorf, Mediget Teshome, et al.Plastic and Reconstructive Surgery|May 3, 2011
Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapyRanjna Sharma, Loren L Rourke, Steven J Kronowitz, et al.Cancer Immunology, Immunotherapy : CII|May 1, 2016
Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cellsAkhil Chawla, Gheath Alatrash, Anne V Philips, et al.Annals of Surgical Oncology|July 28, 2022
Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORxOlga Kantor, Harold J Burstein, Tari A King, et al.Annals of Surgical Oncology|July 13, 2019
SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast CancerMichael D Alvarado, Elizabeth A Mittendorf, Mediget Teshome, et al.Pageof 43